Back to Type 2 Diabetes

Type 2 Diabetes: patient access summary

A printable summary of what is publicly known about access to treatment for Type 2 Diabetes in Australia: PBS subsidy, Australian trial recruitment, and where the gaps are. Nothing here is new information; it is the same reviewed data as the Type 2 Diabetes page, laid out to print. Not medical advice.

Access in Australia

Can you access treatment for Type 2 Diabetes in Australia right now? Here's what's publicly known.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Clinical trial activity

Counted from the nightly snapshot of the full public trial registry data Voxsanity holds for Type 2 Diabetes.
Trials on record 5,450 This is every trial tagged to this condition at any stage whose registry record agrees it is for this condition, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
Recruiting now 393 This counts only trials whose registry status is "Recruiting" and whose registry record agrees they are for this condition. Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
Recruiting with an AU site 12 This counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
Phase 3 trials 18 This counts trials counted under "Recruiting now" that are at Phase 3.

The trial catalogue is checked nightly, but individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Trials recruiting at Australian sites

Why this list is shorter than "Trials on record". Of the 5,450 trials on record for Type 2 Diabetes, 626 are listed on Voxsanity. The list carries trials we can show a plain English summary for: every trial open or about to open to new participants, plus concluded trials that have published their results. The great majority of the difference is research that finished without publishing a results summary, so there is nothing to read and nothing to join. A smaller part is trials that are open now but whose plain English summary has not been written yet. Nothing is being withheld: the larger figure counts research history, this list counts what is useful to read today.

12 of them are recruiting and list at least one Australian site. A listed site is not proof it is enrolling today; confirm with the trial's own contacts before relying on it.

Registry ID Phase Sponsor Status
NCT05345327 Phase 3 The George Institute Recruiting
NCT06579404 Not Applicable University of Cambridge Recruiting
NCT06908486 Not Applicable University of Sydney Recruiting
NCT06937203 Phase 2 Arrowhead Pharmaceuticals Recruiting
NCT06942195 Not Applicable University of Adelaide Recruiting
NCT07091162 Not Applicable Monash University Recruiting
NCT07098663 Phase 2 Mankind Pharma Limited Recruiting
NCT07215559 Phase 2 Eli Lilly and Company Recruiting
NCT07351058 Phase 3 Hoffmann-La Roche Recruiting
NCT07564414 Phase 3 Novo Nordisk A/S Recruiting
NCT07662213 Phase 3 AstraZeneca Recruiting
NCT07664553 Phase 3 AstraZeneca Recruiting

Full eligibility for each trial is at voxsanity.com.au/trials/<registry ID>/, and on the registry itself: clinicaltrials.gov, or isrctn.com for an ISRCTN ID.

PBS-subsidised medicines

Updated nightly, except PBS listing data, which is updated monthly because the PBS publishes a new Schedule once a month.

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. The Government price column is the PBS-determined price the Government pays the pharmacy for the item — it is not what you pay at the counter. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest. Confirm the current amount with your pharmacist.

Medicine Brand(s) Listed for Government pricenot what you pay Authority
Alogliptin Nesina Diabetes mellitus type 2 AU$35.8 Streamlined authority
Alogliptin + metformin Nesina Met 12.5/1000, Nesina Met 12.5/500, Nesina Met 12.5/850 Diabetes mellitus type 2 AU$37.13 Streamlined authority
Dapagliflozin Forxiga Diabetes mellitus type 2 AU$36.42 Streamlined authority
dapagliflozin + metformin Xigduo XR 10/1000, Xigduo XR 10/500, Xigduo XR 5/1000 Diabetes mellitus type 2 AU$36.37 Streamlined authority
Dapagliflozin + sitagliptin Sidapvia 10/100 Diabetes mellitus type 2 AU$49.61 Streamlined authority
Dulaglutide Trulicity Diabetes mellitus type 2 AU$111.44 Authority required
Empagliflozin Jardiance Diabetes mellitus type 2 AU$39.02 Streamlined authority
Empagliflozin + linagliptin Glyxambi Diabetes mellitus type 2 AU$59.71 Streamlined authority
Empagliflozin + metformin Jardiamet 12.5 mg/1000 mg, Jardiamet 12.5 mg/500 mg, Jardiamet 5 mg/1000 mg +1 more Diabetes mellitus type 2 AU$39.5 Streamlined authority
Linagliptin Trajenta Diabetes mellitus type 2 AU$38.36 Streamlined authority
Linagliptin + metformin Trajentamet Diabetes mellitus type 2 AU$40.23 Streamlined authority
Pioglitazone Actos, ARX-PIOGLITAZONE Diabetes mellitus type 2 AU$6.18 Restricted benefit
Saxagliptin Onglyza Diabetes mellitus type 2 AU$35.8 Streamlined authority
Saxagliptin + metformin Kombiglyze XR 2.5/1000, Kombiglyze XR 5/1000, Kombiglyze XR 5/500 Diabetes mellitus type 2 AU$36.54 Streamlined authority
Semaglutide Ozempic Diabetes mellitus type 2 AU$111.44 Authority required
Sitagliptin Sitagliptin Sandoz Pharma Diabetes mellitus type 2 AU$16.48 Streamlined authority
Sitagliptin + metformin Janumet XR, Velmetia Diabetes mellitus type 2 AU$20.33 Streamlined authority
Vildagliptin Galvus Diabetes mellitus type 2 AU$25.52 Streamlined authority
Vildagliptin + metformin ARX-Vildagliptin/Metformin 50/1000, ARX-Vildagliptin/Metformin 50/500, ARX-Vildagliptin/Metformin 50/850 Diabetes mellitus type 2 AU$25.58 Streamlined authority
Finerenone Kerendia Chronic kidney disease with Type 2 diabetes AU$66.08 Streamlined authority

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

What this summary does not cover

  • Australian registration dates. Voxsanity holds no TGA registration record for any medicine, so no Australian registration date appears here or anywhere on this site. The TGA's own Australian Register of Therapeutic Goods (tga.gov.au/resources/artg) is the authoritative place to check. Where a medicine is on the PBS it must already be registered for supply in Australia, because a PBS listing cannot happen before that: that is read from the PBS, not from the TGA.
  • Access outside the PBS and outside a trial. Where a medicine is not registered or not available through a trial, the TGA Special Access Scheme may allow a doctor to apply for access for an individual patient. A plain English explainer is at voxsanity.com.au/sas-navigator/.
  • Whether any of it is appropriate. Nothing on this sheet is a recommendation. A medicine being subsidised, or a trial recruiting nearby, says nothing about whether either suits a particular person. That is a clinical judgement this sheet cannot make.

Not medical advice. Voxsanity republishes public government health data in plain English and does not provide medical advice. Always consult a qualified health professional before making any health decision. Trial status should be verified directly with the trial site. Sources: ClinicalTrials.gov and other public trial registries, and the Pharmaceutical Benefits Scheme.